Cargando…
Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients
Partial congenital hypogonadotropic hypogonadism (PCHH) is caused by an insufficiency in, but not a complete lack of, gonadotropin secretion. This leads to reduced testosterone production, mild testicular enlargement, and partial pubertal development. No studies have shown the productivity of sperma...
Autores principales: | Hao, Ming, Nie, Min, Yu, Bing-Qing, Gao, Yin-Jie, Wang, Xi, Ma, Wan-Lu, Huang, Qi-Bin, Zhang, Rui, Mao, Jiang-Feng, Wu, Xue-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406096/ https://www.ncbi.nlm.nih.gov/pubmed/31464203 http://dx.doi.org/10.4103/aja.aja_88_19 |
Ejemplares similares
-
Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients
por: Liu, Zhaoxiang, et al.
Publicado: (2016) -
Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
por: Sahib, Bahaa O, et al.
Publicado: (2023) -
Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2017) -
Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study
por: Hao, Ming, et al.
Publicado: (2021) -
Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism
por: Ortac, Mazhar, et al.
Publicado: (2019)